Comparative effects of sesame seed lignan and flaxseed lignan in reducing the growth of human breast tumors (MCF-7) at high levels of circulating estrogen in athymic mice

Nutrition and Cancer

Volumn 64, Issue 1, 2012, Pages 65-71

  Truan, Jennifer S ^a   Chen, Jian Min ^a   Thompson, Lilian U ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN; ESTROGEN RECEPTOR; LIGNAN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; SECOISOLARICIRESINOL DIGLUCOSIDE; SESAMIN; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BODY WEIGHT; BREAST TUMOR; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFECT; FOOD INTAKE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LINSEED; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SESAME;

ANIMALS; APOPTOSIS; BODY WEIGHT; BREAST NEOPLASMS; BUTYLENE GLYCOLS; CELL LINE, TUMOR; CELL PROLIFERATION; DIOXOLES; EATING; ESTROGENS; FEMALE; FLAX; GLUCOSIDES; HUMANS; LIGNANS; MICE; MICE, NUDE; RECEPTOR, ERBB-2; RECEPTOR, IGF TYPE 1; RECEPTORS, ESTROGEN; SEEDS; SESAMUM; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS; SESAMUM INDICUM;

EID: 84863127145     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2012.630165     Document Type: Article

References (48)

1. Thompson LU, Boucher BA, Liu Z, Cotterchio M, and Kreiger N. Phytoestrogen content of foods consumed in Canada, including isoflavones, lignans, and coumestan. Nutr Cancer 54, 184-201, 2006. (Pubitemid 44316301)
2. MazurW: Phytoestrogen content in foods. Baillieres Clin Endocrinol Metab 12, 729-742, 1998. (Pubitemid 29261280)
3. Wu WH: The contents of lignans in commercial sesame oils of Taiwan and their changes during heating. Food Chem 104, 341-344, 2007.
4. Liu Z, Saarinen NM, and Thompson LU: Sesamin is one of the major precursors of mammalian lignans in sesame seed (Sesamum indicum) as observed in vitro and in rats. J Nutr 136, 906-912, 2006.
5. Penalvo JL, Heinonen SM, Aura AM, and Adlercreutz H. Dietary sesamin is converted to enterolactone in humans. J Nutr 135, 1056-1062, 2005. (Pubitemid 40645290)
6. Rickard SE, Orcheson LJ, Seidl MM, Luyengi L, Fong HHS,.et al. Dosedependent production of mammalian lignans in rats and in vitro from the purified precursor secoisolariciresinol diglycoside in flaxseed. J Nutr 126, 2012-2019, 1996. (Pubitemid 26260223)
7. Penttinen P, Jaehrling J, Damdimopoulos AE, Inzunza J, Lemmen JG,.et al. Dirt derived polyphenol metabolite enterolactone is a tissue-specific estrogen receptor activator. Endocrinology 148, 4875-4886, 2007. (Pubitemid 47481543)
8. Power KA, Chen J, Saarinen NM, and Thompson LU: Changes in biomarkers of estrogen receptor and growth factor signaling pathways in MCF-7 tumors after short- and long-term treatment with soy and flaxseed. J Steroid Biochem Mol Biol 112,13-19, 2008.
9. Saggar JK, Chen J, Corey P, and Thompson LU: The effect of secoisolariciresinol diglucoside and flaxseed oil, alone and in combination, on MCF-7 tumor growth, cell proliferation, apoptosis and estrogen receptor and growth factor signaling. Nutr Cancer 62, 533-542, 2010.
10. Chen J, Power KA, Mann J, Cheng A, and Thompson LU: Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen. Exp Biol Med 232,1071-1080, 2007. (Pubitemid 47358190)
11. Chen J, Hui E, Ip T, and Thompson LU: Dietary flaxseed enhances the inhibitory effect of tamoxifen on the growth of estrogen-dependent human breast cancer (MCF-7) in nude mice. Clin Cancer Res 10, 7703-7711, 2004. (Pubitemid 39557535)
12. Saarinen NM, Power KA, Chen J, and Thompson LU: Flaxseed attenuates the tumor growth stimulating effect of soy protein in ovariectomized athymic mice with MCF-7 human breast cancer xenografts. Int J Cancer 119, 925-931, 2006. (Pubitemid 44051460)
13. Chen J, Power KA, Mann J, Cheng A, and Thompson LU: Dietary flaxseed interaction with tamoxifen induced tumor regression in athymic mice with MCF-7 xenografts by down-regulating the expression of estrogen related gene products and signal transduction pathways. Nutr Cancer 58, 162-170, 2007. (Pubitemid 47328768)
14. Saggar JK, Chen J, Corey P, and Thompson LU: Dietary flaxseed lignan or oil combined with tamoxifen treatment affects MCF-7 tumor growth through estrogen receptor- and growth factor-signaling pathways. Mol Nutr Food Res 54, 415-425, 2010.
15. Chen J, Saggar JK, Corey P, and Thompson LU: Flaxseed and pure secoisolariciresinol diglucoside, but not flaxseed hull, reduce human breast tumor growth (MCF-7) in athymic mice. J Nutr 139, 2061-2066, 2009.
16. Chen J, Stavro PM, and Thompson LU: Dietary flaxseed inhibits human breast cancer growth and metastasis and downregulates expression of insulin-like growth factor and epidermal growth factor receptor. Nutr Cancer 43, 187-192, 2002. (Pubitemid 36134093)
17. Dabrosin C, Chen J,Wang L, and Thompson LU: Flaxseed inhibits metastasis and decreases extracellular vascular endothelial growth factor in human breast cancer xenografts. Cancer Lett 185, 31-37, 2002. (Pubitemid 34876530)
18. Thompson LU, Chen JM, Li T, Strasser-Weippl K, and Goss PE: Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clin Cancer Res 11, 3828-3835, 2005. (Pubitemid 40685603)
19. Sacco SM, Chen J, Power KA, Ward WE, and Thompson LU: Lignan-rich sesame seed negates the tumor-inhibitory effect of tamoxifen but maintains bone health in a postmenopausal athymic mouse model with estrogenresponsive breast tumors. Menopause 15, 171-179, 2008.
20. Sacco SM, Power KA, Chen J, Ward WE, and Thompson LU: Interaction of sesame seed and tamoxifen on tumor growth and bone health in athymic mice. Exp Biol Med 232, 754-761, 2007. (Pubitemid 46827817)
21. Pianjing P, Thiantanawat A, Rangkadilok N, Watchanasit P, Mahidol C,.et al. Estrogenic activities of sesame lignans and their metabolites on human breast cancer cells. J Agric Food Chem 59, 212-221, 2011.
22. Anagnostis A and Papadopulos AI: Effects of a diet rich in sesame (Sesamum indicum) pericarp on the expression of oestrogen receptor and oestrogen beta in rat prostate and uterus. Br J Nutr 102, 703-708, 2009.
23. Yokota T, MatsuzakiY,KoyamaM,Hitomi T, Kawanaka M,.et al. Sesamin, a lignan of sesame, downregulates cyclin D1 protein expression in humantumor cells. Cancer Sci 98, 1447-1453, 2007. (Pubitemid 47241769)
24. Coulman KD, Liu Z, Hum WQ, Michaelides J, and Thompson LU: Whole sesame seed is as rich a source of mammalian lignan precursors as whole flaxseed. Nutr Cancer 52, 156-165, 2005. (Pubitemid 41579758)
25. Canadian Council on Animal Care: Guide to the care and use of experimental animals: Volume 1, 2nd ed., Ottawa, Canada: CCAC, 1993.
26. Reeves PG, Nielsen FH, and Fahey Jr. GC: AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123, 1939-1951, 1993. (Pubitemid 23342492)
27. Wang L, Chen JM, and Thompson LU: The inhibitory effect of flaxseed on the growth and metastasis of estrogen receptor negative human breast cancer xenografts is attributed to both its lignan and oil components. Int J Cancer 116, 793-798, 2005. (Pubitemid 41099712)
28. Truan JS, Chen J, and Thompson LU: Flaxseed oil reduces the growth of human breast tumors (MCF-7) at high levels of circulating estrogen. Mol Nutr Food Res 54, 1414-1421.
29. Rannevik G, Jeppsson S, Johnell O, Bjerre B, Laurell-Borulf Y,.et al. A longitudinal study of the perimenopausal transition: Altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas 21, 103-113, 1995.
30. Rosenberg CR, Pasternack BS, Shore RE, Koenig KL, and Toniolo PG: Premenopausal estradiol levels and the risk of breast cancer: A new method of controlling for day of the menstrual cycle. Am J Epidemiol 140, 518-525, 1994. (Pubitemid 24285934)
31. Ealey KN, El-Sohemy A, and Archer MC: Effects of dietary conjugated linoleic acid on the expression of uncoupling proteins in mice and rats. Lipids 37, 853-861, 2002. (Pubitemid 35332923)
32. Saarinen NM and Thompson LU: Prolonged adminstration of SDG increases lignan excretion and alters lignan tissue distribution in adult male and female rats. Br J Nutr 104, 833-841, 2010.
33. Adlercreutz H. Phyto-oestrogens and cancer. Lancet Oncol 3, 364-373, 2002. (Pubitemid 34661986)
34. Harikumar KB, Sung B, Tharakan ST, Pandey MK, Joy B,.et al. Sesamin manifests chemopreventive effects through the suppression of NF-kappa B-regulated cell survival, proliferation, invasion, and angiogenic gene products. Mol Cancer Res 8, 751-761, 2010.
35. Bergman-Jungestrom M, Thompson LU, and Dabrosin C. Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo. Clin Cancer Res 13, 1061-1067, 2007. (Pubitemid 46340386)
36. Saarinen NM, Huovinen R, Warri A, Makela SI, Valentin-Blasini L,. et al.Enterolactone inhibits the growth of 7,12-dimethylbenz(a)anthraceneinduced mammary carcinomas in the rat. Mol Cancer Ther 1, 869-876, 2002.
37. Power KA, Saarinen NM, Chen JM, and Thompson LU: Mammalian lignans enterolactone and enterodiol, alone and in combination with the isoflavone genistein, do not promote the growth of MCF-7 xenografts in ovariectomized athymic nude mice. Int J Cancer 118, 1316-1320, 2006. (Pubitemid 43185623)
38. Thompson LU, Rickard SE, Orcheson LJ, and Seidl MM: Flaxseed and its lignan and oil components reduce mammary tumor growth at a late stage of carcinogenesis. Carcinogenesis 17, 1373-1376, 1996. (Pubitemid 26197671)
39. Chen J and Thompson LU: Lignans and tamoxifen, alone or in combination, reduce human breast cancer cell adhesion, invasion and migration in vitro. Breast Cancer Res Treat 80, 163-170, 2003. (Pubitemid 36886504)
40. Heinonen S, Nurmi T, Liukkonen K, Poutanen K, Wahala K,.et al. In vitro metabolism of plant lignans: New precursors of mammalian lignans enterolactone and enterodiol. J Agric Food Chem 49, 3178-3186, 2001. (Pubitemid 32845044)
41. Grougnet R, Magiatis P, Mitakou, and Skaltsounis A. Sesame seed coat: A rich source of potential mammalian lignan precursors. In: Sesame: The genus Sesamum, Bedigian D, ed. Boca Raton, FL: CRC Press, 2010, pp. 91-108.
42. Ostlund RE, Racette SB, Okeke A, and Stenson WF: Phytosterols that are naturally present in commercial corn oil significantly reduce cholesterol absorption in humans. Am J Clin Nutr 75, 1000-1004, 2002. (Pubitemid 34547528)
43. Kim JB, O'Hare MJ, and Stein R. Models of breast cancer: Is merging human and animal models the future? Breast Cancer Res 6, 22-30 2004. (Pubitemid 38195557)
44. Osborne CK: Athymic nude mouse model for the study of new antioestrogens in breast cancer. Breast 5, 181-185, 1996. (Pubitemid 26234107)
45. Rygaard J and Povlsen CO: The nude mouse vs. the hypothesis of immunological surveillance. Transplant Rev 28, 43-61, 1976.
46. Furr BJA and Jordan VC: The pharmacology and clinical uses of tamoxifen. Pharmacol Ther 25,127-205, 1984. (Pubitemid 14015738)
47. Yue W and Brodie A. MCF-7 human breast carcinomas in nude mice as a model for evaluating aromatase inhibitors. J Steroid Biochem Mol Biol 44, 671-673, 1993. (Pubitemid 23126645)
48. Fabian CJ, Kimler BF, Zalles CM, Klemp JR, Petroff BK,.et al. Reduction in Ki-67 in benign breast tissue of high-risk women with the lignan secoisolariciresinol dyglycoside. Cancer Prev Res 3, 1342-1350, 2010.